EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

M1-primed human corneal stromal stem cell-derived exosomes delivering protein-coding transforming growth factor-β3 RNA promote corneal regeneration

Mithun Santra, Elizabeth Rubin, Syeda R Ali, Moira L Geary, Christine Chandran, Julia T Coelho, Ella J Dewald, Xi Cheng, Martha L Funderburgh, Deepinder K Dhaliwal, Xin D Gao, Vishal Jhanji und 1 weitere

Stem Cells Translational Medicine · 2026

DOI: 10.1093/stcltm/szag079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells Translational Medicine, 2026. Verfasst von Mithun Santra und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Corneal Regeneration Lab, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, United States. Hauptthemen laut MEDLINE: Transforming Growth Factor beta3, Exosomes, Regeneration, Corneal Stroma. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hillman Foundation, Research to Prevent Blindness and National Eye Institute, National Institutes of Health (NIH) Regenerative Medicine Innovation Project (RMIP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Human corneal stromal stem cells (hCSSCs), which exhibit mesenchymal stem cell (MSC) features, prevent fibrotic scarring and promote regeneration of injured stromal tissue, thereby restoring corneal clarity in mice. These therapeutic effects rely on hCSSCs’ ability to respond to early inflammatory cues, suppress chronic neutrophil infiltration, and inhibit fibrosis. In this study, we examined the responses of hCSSCs to transient pro-inflammatory M1 stimulation and characterized the exosomes (Exo) they secreted.

Methods

We evaluated the expression of full-length protein-coding human TGFB3 mRNA molecules in purified Exo, and investigated Exo uptake, induction of human transforming growth factor β3 (hTGFβ3) protein expression, and the effects of different hTGFβ3/β1 ratios on myofibroblast generation from human corneal stromal keratocytes (CSKs) and stromal fibroblasts (SFs). The anti-scarring effect of hCSSC-Exo enriched in TGFB3 mRNA was assessed in a mouse model of acute corneal stromal injury.

Results

Our results showed that hCSSC-Exo contained TGFB3 mRNA transcripts, and their abundance increased following pro-inflammatory M1 stimulation. Exo uptake enhanced hTGFβ3 protein expression in hCSKs, and a higher hTGFβ3/β1 ratio in hCSKs and hSFs suppressed expression of α-smooth muscle actin and TGFβ1-induced myofibroblast differentiation. In vivo, topical treatment with M1-primed hCSSC-Exo reduced corneal opacity compared with sham-treated controls. Notably, hCSSC-Exo enriched with TGFB3 mRNA demonstrated greater scar-reducing and wound-healing efficacy.

Conclusions

M1-primed hCSSC-Exo containing protein-coding TGFB3 mRNA significantly inhibited corneal opacity and promoted scar-free healing in injured mouse corneas. These findings support the anti-fibrotic and regenerative potential of hCSSC-Exo, which can be developed as a cell-free therapeutic strategy for corneal fibrosis and scarring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor beta3ExosomesRegenerationCorneal StromaMesenchymal Stem CellsCorneaHumansAnimalsMiceRNA, MessengerMice, Inbred C57BL

Stichwörter der Autor:innen

corneal opacitycorneal stromal stem cellsexosomesprotein-codingtransforming growth factor β3

Substanzen

Transforming Growth Factor beta3TGFB3 protein, humanRNA, Messenger

Autor:innen und Institutionen

  • Department of Ophthalmology, Corneal Regeneration Lab, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, United States.
  • Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, United States.
  • Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15219, United States.
  • Institute for Synthetic Biology, University of Pittsburgh, Pittsburgh, PA 15219, United States.
  • McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15219, United States.

ORCID-Profile: Gary H F Yam

Förderung

  • Hillman Foundation
  • Research to Prevent Blindness and National Eye Institute
  • National Institutes of Health (NIH) Regenerative Medicine Innovation Project (RMIP)
  • NEI NIH HHS
  • Eye and Ear Foundation of Pittsburgh

Zitieren

APA

Santra, M., Rubin, E., Ali, S. R., Geary, M. L., Chandran, C., Coelho, J. T., Dewald, E. J., Cheng, X., Funderburgh, M. L., Dhaliwal, D. K., Gao, X. D., Jhanji, V., & Yam, G. H. F. (2026). M1-primed human corneal stromal stem cell-derived exosomes delivering protein-coding transforming growth factor-β3 RNA promote corneal regeneration. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szag079

Vancouver

Santra M, Rubin E, Ali SR, Geary ML, Chandran C, Coelho JT, et al. M1-primed human corneal stromal stem cell-derived exosomes delivering protein-coding transforming growth factor-β3 RNA promote corneal regeneration. Stem Cells Translational Medicine. 2026. doi:10.1093/stcltm/szag079

BibTeX
@article{Santra2026,
  author = {Santra, Mithun and Rubin, Elizabeth and Ali, Syeda R and Geary, Moira L and Chandran, Christine and Coelho, Julia T and Dewald, Ella J and Cheng, Xi and Funderburgh, Martha L and Dhaliwal, Deepinder K and Gao, Xin D and Jhanji, Vishal and Yam, Gary H F},
  title = {M1-primed human corneal stromal stem cell-derived exosomes delivering protein-coding transforming growth factor-β3 RNA promote corneal regeneration},
  journal = {Stem Cells Translational Medicine},
  year = {2026},
  doi = {10.1093/stcltm/szag079}
}
Kostenlos starten →